Pfizer reported a 4 percent drop in quarterly revenue, while Merck posted earnings that topped expectations.» Read More
The U.S. Food and Drug Administration warned that popular acne products can cause rare but serious and life-threatening allergic reactions.
A crisis of GM proportions awaits the US if we don't fix some big problems like tax reform and Social Security, says Loews co-chair Andrew Tisch.
Most insurers in Florida aren't disclosing their Obamacare rates for next year because they say they are trade secrets.
The uninsured rate in the US has fallen due to Obamacare, but the wide ranges of rates in individual states could actually grow wider.
Vertex Pharmaceuticals' spike Tuesday had investors looking for the next breakout stock. UBS's Matt Roden likes these names.
The British Medical Association voted on Tuesday in favor of a lifelong ban on cigarette sales to people born after 2000.
A longtime contraction in employer health-care spending is set to end in 2015 and resume an upward trend, according to a forecast.
A combination of Vertex drugs met the goals of two late-stage clinical trials in cystic fibrosis, setting the stage for Vertex to apply for approval.
A U.S. Senate panel asked the Centers for Disease Control and Prevention to explain the breach that exposed many to live anthrax, a deadly pathogen.
A government agency is claiming that the VA's own investigation of itself holds contradictions, CNBC has learned.
Vertex's Kalydeco was the first medicine to address the underlying genetic cause. A new drug combination, Kalydeco and Lumacaftor, is designed to treat many additional cases.
Allergan advised investors not to sell their shares to Valeant, which launched a hostile takeover offer for the Botox maker last week.
Expanding Medicaid eligibility will significantly affect uninsured rates in seven major cities, and bring them billions in federal money, according to a study.
Researchers have discovered that an FDA-approved arthritis drug may hold the secret to curing hairlessness.
Genetics startup 23andMe said it is one step closer to resuming sales of its full-fledged health product.
Wealthy Americans worry about the impact of high health care costs in old age, and see it as one of the biggest risks to their financial security.
People who had their old health care plans canceled aren't necessarily paying higher premiums under Obamacare, according to a Kaiser Family Foundation survey.
Prosecutors have issued subpoenas in an investigation into whether congressional staff tipped stock traders to a change in health-care policy. The WSJ reports.
People who receive subsidies and opted for the second-cheapest group HealthCare.gov plans now pay just $69 per month on average in premiums.
ZocDoc is the new king of New York start-ups.
Get the best of CNBC in your inbox